Researchers identify a relationship between exercise activity and television habits in relation to mortality in survivors of colorectal cancer.
[Journal of Gastrointestinal Oncology] This study examines outcomes of CEC patients treated with CRT and the incidence and potential role of HPV tumor infection in CEC lesions.
Update on available treatment options and potential future developments for metastatic melanoma with and without BRAF mutations.
Underlying malignancy is a potential cause of nonbacterial thrombotic endocarditis, understanding symptoms and treatment options is important.
CTA Board Member Steven Cohen, MD, discusses exciting advances regarding treatment options for metastatic pancreatic cancer.
As key biologics near the end of their patent-protection periods, industry is preparing for legal battles over biosimilar versions.
Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
[Lung Cancer: Targets and Therapy] The appropriate role of EGFR mutation analysis in the treatment of patients with NSCLC is constantly evolving; EGFR mutation testing can help simplify the drug discovery process and individualize cancer therapy.
Recent analysis indicated an increase in survival in gastric cancer patients who received chemoradiation compared with chemotherapy alone.
Rociletinib may be effective in treating patients with advanced EGFR-mutated NSCLC with or without the T790M mutation.
Fever is a common symptom for patients with cancer who have neutropenia and it is often difficult to determine if they are in infectious in etiology.
Prostate specific antigen (PSA) screening in some cases led to overdetection of prostate cancer, and now the same is occurring with recurrence.
[Cancer Control] Castleman disease is a lesser seen lymphoproliferative disorder, which is characterized as either localized or multicentric, with differing treatments typically utilized for each type.
The Eastern Cooperative Oncology Group (ECOG) conducted a trial to investigate whether treatment deintensification was feasible in patients with HPV-associated cancer.
NSAIDs target stem cells that have accumulated mutations that could lead to cancer development and a biochemical pathway that leads to apoptosis.
Many changes occur in the gastrointestinal tract during the aging process that can directly impact gastric motility following surgery.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
Cancer Therapy Advisor Articles
- MM-398: A Potential New Option for Metastatic Pancreatic Cancer?
- Disappointing Results for Dual Anti-HER2 Therapy Without Chemotherapy
- Ovarian Suppression Improves Prevention of HR-Positive Breast Cancer Recurrence
- Carboplatin Associated with Better Outcomes than Docetaxel in Advanced BRCA1/2-mutation Breast Cancer
- 10-Year Update Confirms Long-Term Survival Benefits for Weekly Paclitaxel
- Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Burkitt Lymphoma
- Chemoradiation Therapy May Benefit Some Patients with Resectable Gastric Cancer
- Linifanib Fails to Meet Overall Survival Endpoint for Advanced Hepatocellular Carcinoma
- Adding Carfilzomib to Lenalidomide Improves Survival in Relapsed Multiple Myeloma
- More Activity, Less Television Reduces Mortality in Colorectal Cancer Survivors
- Palbociclib Doubles PFS in Women with Advanced Breast Cancer
- The Effect of Voriconazole Treatment on Pediatric Patients: A Retrospective Analysis
- Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma
- For Lymphoma Patients Receiving R-CHOP, Entecavir More Effective for HBV-Related Hepatitis Prophylaxis